Stay updated on Dose-escalating GEM333 in Acute Myeloid Leukemia Clinical Trial

Sign up to get notified when there's something new on the Dose-escalating GEM333 in Acute Myeloid Leukemia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dose-escalating GEM333 in Acute Myeloid Leukemia Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The screenshots show only minor formatting and layout adjustments to the Study Details page, with no changes to core data such as enrollment, status, or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T13:11:05.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    31 days ago
    Change Detected
    Summary
    Major changes: updated operating status notice and version to v3.2.0; removal of v3.1.0.
    Difference
    4%
    Check dated 2025-10-05T22:46:53.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T19:33:01.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.1 to v3.0.2 and removed the Back to Top element. No substantive changes to core content, pricing, stock, or time-sensitive information.
    Difference
    0.2%
    Check dated 2025-09-14T07:49:46.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.2%
    Check dated 2025-09-07T01:34:11.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of specific facility names and locations related to AvenCell Therapeutics, Inc., as well as a revision update to version 3.0.0. Notably, several previous terms and locations have been removed, indicating a shift in focus or rebranding.
    Difference
    4%
    Check dated 2025-08-31T00:45:09.000Z thumbnail image

Stay in the know with updates to Dose-escalating GEM333 in Acute Myeloid Leukemia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dose-escalating GEM333 in Acute Myeloid Leukemia Clinical Trial page.